81 results
424B3
LAB
Standard BioTools Inc.
1 Dec 23
Prospectus supplement
4:33pm
—Litigation Relating to the Merger” beginning on page 135 of this joint proxy statement/prospectus.
The outcome of this lawsuit or any other lawsuit … . Accordingly, if this lawsuit or any future lawsuit is successful in obtaining any order enjoining consummation of the Merger, then such order may prevent
S-4/A
LAB
Standard BioTools Inc.
30 Nov 23
Registration of securities issued in business combination transactions (amended)
9:13pm
/prospectus.
The outcome of this lawsuit or any other lawsuit that may be filed challenging the Merger is uncertain. One of the conditions … of enjoining or otherwise prohibiting the consummation of the Merger. Accordingly, if this lawsuit or any future lawsuit is successful in obtaining any order
S-4
LAB
Standard BioTools Inc.
13 Nov 23
Registration of securities issued in business combination transactions
9:35pm
BioTools Board could prevent or delay the consummation of the Merger.
The outcome of any lawsuit that may be filed challenging the Merger … Agreement having the effect of enjoining or otherwise prohibiting the consummation of the Merger. Accordingly, if any future lawsuit is successful
8-K
EX-10.3
LAB
Standard BioTools Inc.
15 May 23
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience
5:14pm
, filed in a lawsuit, or other proceeding, if such filing is made under seal. Finally, I understand an employee who files a lawsuit alleging
PRE 14A
hkyeck1
11 Feb 22
Preliminary proxy
9:31pm
DEFA14A
ozsbampc8p yjp73v
24 Jan 22
Additional proxy soliciting materials
5:27pm
8-K
EX-10.3
4p763yh5elm5zrom6r
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.5
doukrxm 1llykn0ar
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.4
ixthz
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.6
qdvgwb dkkxb5j1ms
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm